By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708



Company News
Shire (SHPG) Launches 2016 Excellence In ADHD Patient Group Awards 6/15/2016 1:54:13 PM
Shire (SHPG) And Kamada Ltd. (KMDA) Announce FDA Approval Of Expanded Label For Self-Infusion Of GLASSIA For The Treatment Of Emphysema Due To Severe AAT Deficiency 6/15/2016 11:28:02 AM
Shire (SHPG) To License PF-00547659 From Pfizer (PFE), Adding To Established And Leading Gastrointestinal Portfolio 6/15/2016 7:23:30 AM
Shire (SHPG) Announces Completion Of Decentralized Procedure In Europe For Immunoglobulin Treatment Cuvitru 6/13/2016 10:41:00 AM
Shire (SHPG) Nabs Breakthrough Tags for Drug to Treat Rare Gastrointestinal Conditions 6/13/2016 6:01:54 AM
Shire (SHPG) To Participate At Two Upcoming Investor Conferences 6/3/2016 10:58:33 AM
Shire (SHPG) Completes Combination With Baxalta (BXLT) Creating The Global Leader In Rare Diseases And Highly Specialized Conditions 6/3/2016 7:48:12 AM
Shire (SHPG) to Hire Up to 200 New Employees for Baxalta (BXLT)'s Kendall Square Research Center 6/3/2016 5:47:17 AM
Shire (SHPG) Receives Positive CHMP Opinion In Europe For Revestive (Teduglutide) For Paediatric Patients With Short Bowel Syndrome 5/27/2016 9:50:50 AM
About 500 Kendall Square Baxalta (BXLT) Staffers in Limbo as Shire (SHPG) Merger Talks Drag On 5/19/2016 6:51:40 AM